Clinical Study

An Exploratory Open-Label Study Of The Effects On Responsive Neurostimulator Eeg Epileptiform Activity After Intranasal Administration Of A Single Dose Of Valtoco® To People With Epilepsy With Previously Implanted Responsive Neurostimulator Systems

Posted Date: Nov 8, 2021

  • Investigator: Michael Privitera
  • Specialties:
  • Type of Study: Drug

The purpose of this research study is to find out if there is a decrease in Responsive Neurostimulator (RNS) recorded abnormal brain wave activity following a single dose of intranasal VALTOCO® (diazepam nasal spray).


Participants Must Be 18 Or Older, Weigh More Than 110 Pounds, And Have Rns Implanted For At Least 3 Months With Stable Settings For At Least 30 Days. Participants My Not Be Pregnant, Have History Of Substance Abuse Within The Previous 2 Years, And Use Recreational Or Medicinal Marijuana In The Prior 30 Days. The Study Team Will Review Other Eligibility Criteria With Anyone Interested In Participating.


Epilepsy, Rns

For More Information:

Lucy Mendoza

  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at or (513) 245-3417.